The IMA Group Acquires Albuquerque Neuroscience, Inc.

September 9, 2021

The IMA Group has acquired Albuquerque Neuroscience, Inc., a clinical research site specializing in central nervous system (CNS) and general medical condition trials. The acquisition expands IMA Clinical Research's national footprint and deepens its capabilities in psychiatry, Alzheimer's disease and other neuropathic therapeutic areas; financial terms were not disclosed.

Buyers
The IMA Group
Targets
Albuquerque Neuroscience, Inc.
Location
New Mexico, United States
Transaction Type
Buyout

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.